These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Expression of stem cell factor (SCF), a KIT ligand, in gastrointestinal stromal tumors (GISTs): a potential marker for tumor proliferation. Hirano K; Shishido-Hara Y; Kitazawa A; Kojima K; Sumiishi A; Umino M; Kikuchi F; Sakamoto A; Fujioka Y; Kamma H Pathol Res Pract; 2008; 204(11):799-807. PubMed ID: 18602222 [TBL] [Abstract][Full Text] [Related]
46. Cell cycle/apoptosis molecule expression correlates with imatinib response in patients with advanced gastrointestinal stromal tumors. Romeo S; Debiec-Rychter M; Van Glabbeke M; Van Paassen H; Comite P; Van Eijk R; Oosting J; Verweij J; Terrier P; Schneider U; Sciot R; Blay JY; Hogendoorn PC; Clin Cancer Res; 2009 Jun; 15(12):4191-8. PubMed ID: 19509155 [TBL] [Abstract][Full Text] [Related]
47. A mouse model of a human multiple GIST family with KIT-Asp820Tyr mutation generated by a knock-in strategy. Nakai N; Ishikawa T; Nishitani A; Liu NN; Shincho M; Hao H; Isozaki K; Kanda T; Nishida T; Fujimoto J; Hirota S J Pathol; 2008 Feb; 214(3):302-11. PubMed ID: 18098338 [TBL] [Abstract][Full Text] [Related]
48. Comparative validation of c-kit exon 11 mutation analysis on cytology samples and corresponding surgical resections of gastrointestinal stromal tumours. Pang NK; Chin SY; Nga ME; Chang AR; Ismail TM; Omar SS; Charlton A; Salto-Tellez M Cytopathology; 2009 Oct; 20(5):297-303. PubMed ID: 19207305 [TBL] [Abstract][Full Text] [Related]
49. A 17 year-old man with an exon 11 mutation of CD-117 causing a gastrointestinal stromal tumor. Bauer TM; Berlin JD Cancer Invest; 2008 Mar; 26(2):182-4. PubMed ID: 18259950 [TBL] [Abstract][Full Text] [Related]
50. KIT exon 11 deletion-inversions represent complex mutations in gastrointestinal stromal tumors. Lasota J; Miettinen M Cancer Genet Cytogenet; 2007 May; 175(1):69-72. PubMed ID: 17498562 [TBL] [Abstract][Full Text] [Related]
51. Secondary C-kit mutation is a cause of acquired resistance to imatinib in gastrointestinal stromal tumor. Zheng S; Pan YL; Tao DY; Wang JL; Huang KE Scand J Gastroenterol; 2009; 44(6):760-3. PubMed ID: 19096980 [TBL] [Abstract][Full Text] [Related]
55. Contemporary pathology of gastrointestinal stromal tumors. Liegl B; Hornick JL; Lazar AJ Hematol Oncol Clin North Am; 2009 Feb; 23(1):49-68, vii-viii. PubMed ID: 19248970 [TBL] [Abstract][Full Text] [Related]
56. Prognostic value of KIT exon 11 deletions in GISTs. Emile JF; Tabone-Eglinger S; Théou-Anton N; Lemoine A Gastroenterology; 2006 Sep; 131(3):976-7; author reply 977-8. PubMed ID: 16952576 [No Abstract] [Full Text] [Related]
57. Molecular pathology of gastrointestinal stromal tumors and implications for treatment and prognosis. Parkin B; Chugh R Curr Probl Cancer; 2011; 35(5):245-54. PubMed ID: 22118564 [No Abstract] [Full Text] [Related]
58. Diagnosis of gastrointestinal stromal tumors from minute specimens: cytomorphology, immunohistochemistry, and molecular diagnostic findings. Layfield LJ; Wallander ML Diagn Cytopathol; 2012 Jun; 40(6):484-90. PubMed ID: 22351482 [TBL] [Abstract][Full Text] [Related]
59. A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor. Ryu MH; Kang WK; Bang YJ; Lee KH; Shin DB; Ryoo BY; Roh JK; Kang JH; Lee H; Kim TW; Chang HM; Park JO; Park YS; Kim TY; Kim MK; Lee WK; Kang HJ; Kang YK Oncology; 2009; 76(5):326-32. PubMed ID: 19307738 [TBL] [Abstract][Full Text] [Related]
60. PDGFRA immunostaining can help in the diagnosis of gastrointestinal stromal tumors. Miselli F; Millefanti C; Conca E; Negri T; Piacenza C; Pierotti MA; Tamborini E; Pilotti S Am J Surg Pathol; 2008 May; 32(5):738-43. PubMed ID: 18360281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]